BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

BioWarn, LLC 

19632 Clubhouse Road
Suite 520
Montgomery Village  Maryland  22124  U.S.A.
Phone: 301-926-9050 Fax: 301-926-8432


SEARCH JOBS

BioWarn, LLC is a biotechnology research and product development company that was formed for the purpose of bringing real-time bio-detection to healthcare, biodefense, and other fields. BioWarn's SmartSense™ system patent has been allowed by the United States Patent and Trademark Office. The SmartSense system represents a substantial leap ahead of current diagnostic and sensing technologies because it is real-time, simple to use, deployable everywhere, and highly affordable.

Unlike other diagnostic and sensor technologies that take between 20 minutes and 20 hours to work, a SmartSense detector is a real-time sensor that uses a highly sensitive microelectronic chip to capture the energy "signature" produced by the binding of a target to the sensor's surface. It is substantially less susceptible than conventional diagnostics to false-positive and false-negative results. Using extremely small samples, the system does not require lab equipment, a lab technician, or special procedures. A SmartSense device makes remote monitoring possible from anywhere a network reaches because it has on-board power and integrated network communications.

Because a fully developed SmartSense device will carry all core functionality on a single microelectronic chip, it will benefit from the scale economies of semiconductor manufacturing. With this affordability the SmartSense system brings advanced pathogen detection into the reach of those who need it the most, such as healthcare, biodefense, and first-responder organizations.

The SmartSense system opens up entirely new possibilities for bio-detection in contexts where throughput is measured in the hundreds of millions of samples-which current diagnostic technologies cannot practically address because they are not rapid enough, and they cost too much. For example, BioWarn is currently developing a SmartSense influenza detector for monitoring the spread of avian flu in animal and human populations.

BioWarn's SmartSense system was created for health care professionals, researchers, scientists, pharmaceutical manufacturers, government agencies, first-responders and others to address the emerging threats of drug-resistant infectious diseases and public health risks from pandemic flu or acts of bioterrorism, such as the anthrax attacks through the U.S. postal system.

About BioWarn, LLC and Defense Group Inc.
Headquartered in Virginia with operations offices in Maryland, BioWarn, LLC is a biotechnology research and product development company that brings full-time, always-on biological substance detection and pathogen surveillance to the healthcare, bio-defense, and other fields. BioWarn, LLC is majority owned by Defense Group Inc. (DGI), which performs work in the national interest, advancing public safety and national security through innovative research, analysis and applied technology.

For more information about BioWarn, LLC and the SmartSense system, visit: www.biowarnllc.com

Last Updated: 06-01-2006

 Key Statistics


Email: biowarn.info@biowarnllc.com
Ownership: Private

Web Site: BioWarn, LLC
Employees:
Symbol: 
 



Industry
Biotechnology






 Company News
BioWarn Announces Instantaneous Detection Of Avian Flu With SmartSense(TM) System: Receives Approval Of Patent Issuance 6/5/2006 2:58:58 PM    More...
BioWarn Announces Instantaneous Detection Of Avian Flu With SmartSense™ System: Receives Approval Of Patent Issuance 6/2/2006 1:54:11 PM    More...

//-->